You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table PDU-1. Prevalence of problem drug use at national level: Summary Table, 2002–06, rate per 1000 aged 15–65 [see all tables in this series...]

Part (ii) Injecting drug use

Country	Notes	Year	Rate /1000 ages 15–64	Interval for rate /1000 [1]	Number of users [1]	Target group, data sources and estimation methods	Reference
Czech Republic		2006	4	[3.5–4.6]	[25 496–33 823]	Current injectors. Low-threshold services and national HCV study among IDUs.	6
Germany	2	2005	1.7	[1.4–2.0]	[78 000–110 500]	Heroin users registered by the police. Mortality multiplier.	18
Estonia	3	2004	15.1	[8.9–37.1]	1 3801	IDUs. Estonian Police Database. Health Insurance Fund. State HIV Reference Laboratory. Capture-recapture.	1
Greece		2006	1.3	[1.1–1.5]	[8 542–11 134]	Current injecting drug users. Treatment data. Capture-recapture.	4
Cyprus		2006	0.6	[0.5–0.7]	[257–382]	Current injectors. Treatment data. Truncated Poisson.	2
Hungary	2	2005	0.6	[0.3–0.8]	[2 069–5 813]	IDUs. Treatment and police data. Capture-recapture.	2
Slovakia		2006	4.9	[3.5–8.9]	[13 732–34 343]	IDUs. Treatment data	1, 3, 4
Finland	4	2002	4.5	[4.3–5.7]	[12 200–19 700]	Current injectors of opiates or stimulants. Multiple sources. Combination of multiplier and capture-recapture.	1
United Kingdom		2005	4	[3.8–4.2]	[151 032–165 696]	IDUs. The UK estimate is based on the England estimate for 2005/06, Northern Ireland for 2004 and Scotland for 2003, extrapolating to Wales from the England estimate.	18
Croatia		2006	1.1	[0.9–1.4]	[2 768–4 128]	Opiate users. Treatment and mortality data.
Norway	2	2005	4.3	[2.6–7.1]	[7 918–21 701]	Overdose deaths, death rates from studies. Mortality multiplier.	4

Notes:

n.a. = not available.

1 - Interval is a 95 % confidence interval.

2 - Confidence Interval not known.

3 - Estonia: Original age range of study was 15–44, rates have been adjusted to 15–64.

4 - Finland: the original age range of study was 15–55, rate was adjusted to 15–64.

For further details on methods and data sources/comments see Table PDU-3 and Table PDU-4.

See also ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

For bibliographic references see Table PDU-4.

Download this data in Excel (.xls) format

(see the help page for information about formats etc.)